Contract Pharma Manufacturing Webinars
-
Leveraging Stable Pool Material To Expedite The Path To IND
1/10/2024
Review the efficacy of fast stable pools in generating purified product at an early stage and learn how to accelerate the journey toward first-in-human trials and proof-of-concept studies.
-
High Potency Manufacturing Solutions
1/9/2024
Observe our experts in action as they scale up projects using a range of techniques and dosage forms, progressing from formulation to the production of commercial-scale batches.
-
Manufacturing And Analytical Testing Solutions
1/9/2024
Explore this contract manufacturing services offering designed to streamline drug development programs, resulting in time and cost savings while expediting the journey to market.
-
Optimization-By-Design - A Critical Factor In Viral Vector Scale Up
12/14/2023
Learn how leveraging the expertise and capabilities of an experienced partner is a key factor in optimizing AAV processes using Design of Experiment (DoE), thereby reducing variability and risk.
-
Nitrosamine Impurities Deadline: Are Your Products Compliant?
12/5/2023
Learn how to select an experienced nitrosamine mitigation provider and how a tailored, quantified strategy can help you bring your product into compliance while maintaining control of the process.
-
Reaching BLA Success: Fast-Track Approach To Process Characterization
11/30/2023
Discover how knowledge of microbial processes and process characterization understanding can be used to design targeted BLA programs while managing risks.
-
CDMO + Emerging Bio Partnership With Forge's John Maslowski And Ray's Jenny Holt
10/25/2023
What constitutes a healthy, productive, and successful relationship between an emerging biopharma company and its contract development and manufacturing outsourcer (CDMO)? Jenny Holt, Chief Development Officer at the biopharma company Ray Therapeutics has some opinions. So does John Maslowski, Chief Commercial Officer at the CDMO Forge Biologics. Think they align?
-
The Fundamental Outsourcing Question All Sponsors Face
10/24/2023
To end our Outsourced Pharma Live event on strategies for quality and regulatory outsourcing challenges, Chief Editor Louis Garguilo emphasizes the crucial question to ask when selecting a CDMO.
-
How To Connect Quality And Regulatory “At The Hip”
10/24/2023
Our Outsourced Pharma Live panel of experts introduce challenges and strategies to ensure your internal – and external partners’ – quality and regulatory professionals work together.
-
File First In Europe, Then The U.S.?
10/24/2023
Karla Knower, Global Head of Regulatory Affairs, Paradigm Biopharmaceuticals, answers a challenging question from an attendee at a recent Outsourced Pharma Live.